Open Access · CC BY 4.0
Kirsten rat sarcoma viral oncogene (KRAS)-targeted therapy across cancer types: Context, resistance, and future directions
Cancer Pathogenesis and Therapy · 2026-10
DOI: 10.1016/j.cpt.2026.10.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Pathogenesis and Therapy, 2026-10. Verfasst von Yunxin Liu und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Liu, Y., & Wang, M. (2026). Kirsten rat sarcoma viral oncogene (KRAS)-targeted therapy across cancer types: Context, resistance, and future directions. Cancer Pathogenesis and Therapy. https://doi.org/10.1016/j.cpt.2026.10.003
Vancouver
Liu Y, Wang M. Kirsten rat sarcoma viral oncogene (KRAS)-targeted therapy across cancer types: Context, resistance, and future directions. Cancer Pathogenesis and Therapy. 2026. doi:10.1016/j.cpt.2026.10.003
BibTeX
@article{Liu2026,
author = {Liu, Yunxin and Wang, Mengzhao},
title = {Kirsten rat sarcoma viral oncogene (KRAS)-targeted therapy across cancer types: Context, resistance, and future directions},
journal = {Cancer Pathogenesis and Therapy},
year = {2026},
doi = {10.1016/j.cpt.2026.10.003}
}
EUVIMED